The Influence of Diabetes on Labor Induction with Dinoprostone Vaginal Inserts

Abstract

Objective The aim of this study was to compare duration of labor induction between diabetic and nondiabetic women receiving dinoprostone vaginal insert (10 mg).

Study Design This is a secondary analysis of two large randomized controlled trials using dinoprostone vaginal inserts for labor induction. We compare time to active labor, overall delivery, and vaginal delivery between diabetic and nondiabetic women undergoing induction of labor with a 10-mg dinoprostone vaginal insert.

Results Diabetic women receiving dinoprostone vaginal insert had a longer time to onset of active labor, overall delivery, and vaginal delivery than their nondiabetic counterparts. There was no difference in abnormal labor affecting fetal heart rate pattern in diabetic women compared with nondiabetic women. The rates of neonatal hyperbilirubinemia were higher in diabetic women.

Conclusion Diabetes may represent an independent factor associated with prolonged induction among women undergoing induction of labor with dinoprostone. Dinoprostone is well tolerated in both diabetic and nondiabetic women.

Key Points

• Diabetic women receiving DVI have slower labor curves than nondiabetic women.

• Nulliparous diabetic women took longer to achieve active labor, overall delivery, and vaginal delivery than nondiabetic women.

• Parous diabetic women took longer to achieve vaginal delivery than nondiabetic women.

Key Words

dinoprostone - diabetes - induction - labor - prostaglandin

Publikationsverlauf

Eingereicht: 08. September 2020

Angenommen: 04. Oktober 2021

Artikel online veröffentlicht:
02. Dezember 2021

• References

• 1 Fong A, Serra A, Herrero T, Pan D, Ogunyemi D. Pre-gestational versus gestational diabetes: a population based study on clinical and demographic differences. J Diabetes Complications 2014; 28 (01) 29-34
• 2 Wu ET, Nien FJ, Kuo CH. et al. Diagnosis of more gestational diabetes lead to better pregnancy outcomes: comparing the International Association of the Diabetes and Pregnancy Study Group criteria, and the Carpenter and Coustan criteria. J Diabetes Investig 2016; 7 (01) 121-126
• 3 ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
• 4 Rosenstein MG, Cheng YW, Snowden JM, Nicholson JM, Doss AE, Caughey AB. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. Am J Obstet Gynecol 2012; 206 (04) 309.e1-7
• 5 Sutton AL, Mele L, Landon MB. et al. Delivery timing and cesarean delivery risk in women with mild gestational diabetes mellitus. Am J Obstet Gynecol 2014; 211 (03) 244.e1-7
• 6 Vilchez GA, Dai J, Hoyos LR, Gill N, Bahado-Singh R, Sokol RJ. Labor and neonatal outcomes after term induction of labor in gestational diabetes. J Perinatol 2015; 35 (11) 924-929
• 7 Melamed N, Ray JG, Geary M. et al. Induction of labor before 40 weeks is associated with lower rate of cesarean delivery in women with gestational diabetes mellitus. Am J Obstet Gynecol 2016; 214 (03) 364.1-8
• 8 Grobman WA, Rice MM, Reddy UM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med 2018; 379 (06) 513-523
• 9 Glazer KB, Danilack VA, Field AE, Werner EF, Savitz DA. Term labor induction and cesarean delivery risk among obese women with and without comorbidities. Am J Perinatol 2022; 39 (02) 154-164
• 10 Bakker R, Pierce S, Myers D. The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach. Arch Gynecol Obstet 2017; 296 (02) 167-179
• 11 Braems G, Norhausen I. Induction of labor with prostaglandins for medical reasons: determining explanatory variables of the induction to delivery time interval for vaginal deliveries and caesarean section. Eur J Obstet Gynecol Reprod Biol 2007; 135 (02) 164-169
• 12 Melamed N, Ben-Haroush A, Kremer S, Hod M, Yogev Y. Failure of cervical ripening with prostaglandin-E2 can it be predicted?. J Matern Fetal Neonatal Med 2010; 23 (06) 536-540
• 13 iang TT, Zhao L, Lin Y. et al. Effects of gestational diabetes mellitus on time to delivery and pregnancy outcomes in full-term pregnancies with dinoprostone labor induction. Clin Exp Hypertens 2019; 41 (01) 44-48
• 14 Hawkins JS, Stephenson M, Powers B, Wing DA. Diabetes mellitus: an independent predictor of duration of prostaglandin labor induction. J Perinatol 2017; 37 (05) 488-491
• 15 Wing DA. Misoprostol Vaginal Insert Consortium. Misoprostol vaginal insert compared with dinoprostone vaginal insert: a randomized controlled trial. Obstet Gynecol 2008; 112 (04) 801-812
• 16 Wing DA, Brown R, Plante LA, Miller H, Rugarn O, Powers BL. Misoprostol vaginal insert and time to vaginal delivery: a randomized controlled trial. Obstet Gynecol 2013; 122 (2, Pt 1): 201-209
• 17 Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012; 41 (03) 861-870
• 18 Ozkan S, Calişkan E, Doğer E, Yücesoy I, Ozeren S, Vural B. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial. Arch Gynecol Obstet 2009; 280 (01) 19-24
• 19 Liu A, Lv J, Hu Y, Lang J, Ma L, Chen W. Efficacy and safety of intravaginal misoprostol versus intracervical dinoprostone for labor induction at term: a systematic review and meta-analysis. J Obstet Gynaecol Res 2014; 40 (04) 897-906
• 20 Chen W, Xue J, Peprah MK. et al. A systematic review and network meta-analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour. BJOG 2016; 123 (03) 346-354
• 21 Maggi C, Mazzoni G, Gerosa V. et al. Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert. Acta Obstet Gynecol Scand 2019; 98 (10) 1268-1273
• 22 Metzger BE, Lowe LP, Dyer AR. et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358 (19) 1991-2002
• 23 Landon MB, Spong CY, Thom E. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361 (14) 1339-1348
• 24 Hay Jr WW. Care of the infant of the diabetic mother. Curr Diab Rep 2012; 12 (01) 4-15
• 25 Thevarajah A, Simmons D. Risk factors and outcomes for neonatal hypoglycaemia and neonatal hyperbilirubinaemia in pregnancies complicated by gestational diabetes mellitus: a single centre retrospective 3-year review. Diabet Med 2019; 36 (09) 1109-1117
• 26 Timofeev J, Huang CC, Singh J, Driggers RW, Landy HJ. Spontaneous labor curves in women with pregnancies complicated by diabetes. J Matern Fetal Neonatal Med 2012; 25 (01) 20-26
• 27 Levast F, Legendre G, Hachem HE. et al. A mathematical model to predict mean time to delivery following cervical ripening with dinoprostone vaginal insert. Sci Rep 2019; 9 (01) 9910
• 28 Jawerbaum A, Gonzalez E. The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy. Curr Pharm Des 2005; 11 (10) 1327-1342
• 29 Vidaeff AC, Ramin SM. Potential biochemical events associated with initiation of labor. Curr Med Chem 2008; 15 (06) 614-619
• 30 Al-Matubsi HY, Salim MD, El-Sharaky AS. et al. Activities of cyclooxygenases, and levels of prostaglandins E2 and F2alpha, in fetopathy associated with experimental diabetic gestation. Diabetes Metab 2010; 36 (01) 43-50
• 31 Pevzner L, Powers BL, Rayburn WF, Rumney P, Wing DA. Effects of maternal obesity on duration and outcomes of prostaglandin cervical ripening and labor induction. Obstet Gynecol 2009; 114 (06) 1315-1321
• 32 Ellis JA, Brown CM, Barger B, Carlson NS. Influence of maternal obesity on labor induction: a systematic review and meta-analysis. J Midwifery Womens Health 2019; 64 (01) 55-67
• 33 Carlson NS, Hernandez TL, Hurt KJ. Parturition dysfunction in obesity: time to target the pathobiology. Reprod Biol Endocrinol 2015; 13: 135